(PharmaNewsWire.Com, June 29, 2017 ) Europe Breast Cancer Screening Market will be less than US$ 8 Billion by the end of year 2022. Breast cancer is one of the most dangerous diseases in the Europe region. Its incidence rate in Europe was 92.9 women per 100,000 women and mortality rate was 23.1 per 100,000 women. So, most of the countries of Europe has adopted or in the process to adopt breast cancer screening in their national cancer screening programs. Mammography screening is most commonly used as breast cancer screening method in Europe.
Germany has the Highest Market Share in Breast Cancer Screening Market, but it will lose its Market Leader Position to United Kingdom in Future
Germany is the clear winner in the breast cancer screening market as it has huge women population, advanced healthcare infrastructure and government supported screening programs. Under the programs, all women age between 50-69 years are eligible for free breast cancer screening test in every two years. Under this program eligible woman gets a letter from the regional mammography program center to participate in the breast cancer screening program.
Germany will maintain their Dominating Position in Europe Breast Cancer Ultrasound Screening Market
Due to strong healthcare expending power and increasing breast cancer awareness among the women, Germany is forecast to hold its dominating place in Europe Breast Cancer Screening Market. Presently, Germany, Italy and Spain are steadily losing their market share on comparison to this all other countries such as United Kingdom, France, Switzerland, Norway and Netherlands ultrasound screening market share is expected to grow in the forecasting period 2017-2022.
The report analyzes the Europe Breast Cancer Mammography Screening Market, Breast Cancer MRI Screening Market and Breast Cancer Ultrasound Screening Market. This report studies separate comprehensive analytics for the 8 countries: United Kingdom, France, Germany, Italy, Spain, Netherlands, Norway and Switzerland.
This 122 page report with 120 Figures and 2 Tables provides a complete analysis of top 8 courtiers of Europe Breast Cancer Screening Market. All the 8 countries in the report have been studied from 7 viewpoints.
- Countries Breast Cancer Mammography Screening Population Scenario and Forecast - Countries Breast Cancer MRI & Ultrasound Screening Population Scenario and Forecast - Countries Breast Cancer Mammography Screening Market and Forecast - Countries Breast Cancer MRI Screening Market and Forecast - Countries Breast Cancer Ultrasound Screening Market and Forecast - Countries Breast Cancer Screening Market and Forecast - Worldwide Breast Cancer Screening Market and Forecast
All the 8 Countries Studied in the Report are as Follows
United Kingdom France Germany Italy Spain Netherlands Norway Switzerland
Table of Content
1 EXECUTIVE SUMMARY
2 EUROPE SCREENING POPULATION ANALYSIS 2.1 Europe Breast Cancer Mammography Screening Population & Forecast 2.2 Europe Breast Cancer MRI & Ultrasound Screening Population & Forecast
3 EUROPE BREAST CANCER SCREENING MARKET ANALYSIS 3.1 Europe Breast Cancer Screening Market & Forecast 3.1.1 Europe Breast Cancer Mammography Screening Market & Forecast 3.1.2 Europe Breast Cancer MRI Screening Market & Forecast 3.1.3 Europe Breast Cancer Ultrasound Screening Market & Forecast
4 EUROPE BREAST CANCER SCREENING POPULATION & MARKET SHARE ANALYSIS 4.1 Europe Breast Cancer Mammography Screening Population Share & Forecast 4.2 Europe Breast Cancer MRI & Ultrasound Screening Population Share & Forecast
5 EUROPE BREAST CANCER SCREENING MARKET SHARE ANALYSIS 5.1 Worldwide Breast Cancer Screening Market Share & Forecast 5.2 Europe Breast Cancer Mammography Screening Market Share & Forecast 5.3 Europe Breast Cancer MRI Screening Market Share & Forecast 5.4 Europe Breast Cancer Ultrasound Screening Market Share & Forecast ....
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
